BT7480

E1266364 UNEXPLORED

BT7480 is an investigational drug candidate developed by Bicycle Therapeutics, based on their bicyclic peptide platform for targeted cancer therapy.

All labels observed (1)

Label Occurrences
BT7480 canonical 1

How this entity was disambiguated

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.